NAD+ for Wellness Clinics: A Growing Retail Category

Short answer: Clinics already in the NAD+ conversation have a natural next shelf item: sublingual NAD+ strips as a take-home retail complement to IV. InstaMed's NAD+ strip is 100 mg per strip, 30-count, in stock at source, and available through its wholesale program — a recognizable molecule, in a format clients don't need an appointment to use.

If your clinic's NAD+ reference point is the infusion chair, this page is about the shelf next to the front desk. For category context, see our wholesale peptides pillar and the med-spa model in peptide strips for med spas.

Why NAD+ is the easy first retail SKU

NAD+ is one of the few supplement-category compounds clinics already know, because many already sell it — as IV infusions. Clients recognize the molecule, ask about it by name, and associate it with energy and healthy aging. That familiarity is retail gold: you're not explaining a new category, you're answering a question the client already has — what do I take home between visits?

The brand's own retail copy describes its NAD+ strip with structure/function language — "promotes healthy cellular energy production," "supports mitochondrial function and resilience" [brand claim — unverified]. Those are the brand's statements, kept at that level here — and they're exactly the kind of conversation your clients are already having.

The SKU, factually

• Energy — NAD+: 100 mg NAD+ per strip, 30-count box, Orange flavor [documented — PRODUCT-DATA].
• Availability: in stock at source [documented — PRODUCT-DATA].
• Documented price reference: the wholesale-side "5ct Case" figure observed on the official storefront is $295 [documented — catalog recon]. That is a wholesale case figure, not consumer retail — the strip retails openly at $118 per 30-strip box.
• Known quality gap, disclosed up front: this SKU's COA has no potency table — it moves from appearance to heavy metals and microbials without a per-strip assay result, and its flavor description conflicts with the label [documented — PRODUCT-DATA]. If you stock it, that's a fair question to raise with the supplier — and we flag it here because we'd want it flagged to us.

Details on the product page: NAD+ sublingual strips.

What the evidence shows — and where it's heading

Established: NAD+ precursors taken orally (NMN, NR) raise blood NAD+ in human trials [published human data]. Intact NAD+ does not survive the gut — which is the entire rationale for non-oral formats, IV and sublingual alike. The molecule's central role in cellular energy metabolism is textbook biochemistry, not hype.

Early-stage but pointing somewhere: for sublingual NAD+ specifically, the most cited dataset is company-sponsored: a rat pharmacokinetic study (18 rats) reporting a two-fold plasma NAD+ peak within 10 minutes of sublingual dosing and a claimed ~22% bioavailability versus IV, plus an open-label, nine-person human pilot reporting average whole-blood NAD+ increases of +59% at two weeks and +76% at six weeks [company-sponsored, not peer reviewed]. Small, sponsor-run, uncontrolled — and directionally encouraging for the format's core question, which is whether a strip can move NAD+ into blood at all. Our sublingual NAD+ vs IV comparison covers the IV relationship in detail, and InstaMed NAD+ strips is the brand-side product page.

The retail-model fit, honestly framed

We won't quote margins or growth rates — there are no verified figures to quote, and inventing them would be exactly the kind of content this category doesn't need. What can be said qualitatively works strongly in this SKU's favor: clinics evaluating a take-home item weigh shelf footprint, client familiarity, and reorder friction, and a flavored orange strip in a small box scores well on all three against, say, a refrigeration-dependent product. Whether the economics work for your practice depends on your client base and your wholesale terms, which sit behind the login.

The honest passage

One passage, because positioning is everything here: if your clients come to you specifically for IV NAD+, a strip is not a substitute and shouldn't be sold as one — the dose-per-session scale and the evidence base are different, and "IV in a strip" would be both inaccurate and corrosive to trust. And if your client base is price-sensitive, a premium supplement retail program may simply not clear your floor. The right pilot is small: one SKU, one shelf, and your own reorder data telling you the truth.

The bottom line

NAD+ is the lowest-friction first retail SKU a wellness clinic can add: the molecule is already famous with your clients, the strip format removes needles from the take-home equation, and the wholesale program gates pricing behind an application rather than promising public tiers. Say the evidence-status sentence out loud to clients — early-stage, company-sponsored — and the honesty becomes part of the offer. The application path is the wholesale page.

---

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

This content is for educational purposes only and is not medical advice. Consult a licensed healthcare provider before starting any new product. Individual results vary.